Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Launched by DASMAN DIABETES INSTITUTE · May 14, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a structured education program can help Arab adolescents aged 11 to 14 manage their type 1 diabetes better. Type 1 diabetes is a condition where the body doesn’t produce insulin, which is needed to control blood sugar levels. Many young people with this condition struggle to keep their blood sugar in a healthy range, leading to complications and affecting their daily lives. In this study, some participants will receive a special educational program designed to improve their understanding of diabetes management, while others will continue with regular care for comparison.
To be eligible for the trial, participants must be Arab adolescents who have been diagnosed with type 1 diabetes for at least six months and are using a continuous glucose monitor (CGM). They should also be able to participate fully in the study with their parents. Participants will take part in assessments, including measuring their growth and blood sugar control, and will fill out questionnaires about their health and lifestyle. Those in the education group will attend a four-day program, including a day for parents, and will keep a food diary during this time. After six months, the control group will also have the chance to join the program. This trial aims to see if education can make a real difference in managing diabetes for these young individuals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Arab adolescents
- • Males and females aged 11 to 14 years.
- • Have been diagnosed with type 1 diabetes for at least 6 months.
- • Wearing a continuous glucose monitor (CGM).
- • Individuals and their parents must be able to join the entire duration of the study.
- • Individuals and their parents must voluntarily provide consent and assent.
- Exclusion Criteria:
- • Presence of learning disabilities or any known psychological issues.
- • Attendance at any diabetes education or carbohydrate counting programs within the six months preceding the study.
About Dasman Diabetes Institute
Dasman Diabetes Institute (DDI) is a leading research and clinical organization dedicated to advancing diabetes care and management through innovative research, education, and community outreach. Established to address the growing prevalence of diabetes, DDI focuses on conducting high-quality clinical trials aimed at developing effective prevention and treatment strategies. The institute collaborates with local and international partners to enhance understanding of diabetes and its complications, fostering a multidisciplinary approach that integrates clinical practice with cutting-edge research. With a commitment to improving patient outcomes, DDI serves as a vital resource for healthcare professionals, researchers, and individuals affected by diabetes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuwait City, Sharq, Kuwait
Patients applied
Trial Officials
Ebaa Al Ozairi, MD
Study Director
Dasman Diabetes Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported